All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

First description of the emergence of Enterobacter asburiae producing IMI-2 carbapenemase in the Czech Republic

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216224%3A14310%2F17%3A00108757" target="_blank" >RIV/00216224:14310/17:00108757 - isvavai.cz</a>

  • Alternative codes found

    RIV/00216208:11140/17:10365174 RIV/00064165:_____/17:10365174

  • Result on the web

    <a href="https://www.sciencedirect.com/science/article/pii/S221371651730187X?via%3Dihub" target="_blank" >https://www.sciencedirect.com/science/article/pii/S221371651730187X?via%3Dihub</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1016/j.jgar.2017.10.001" target="_blank" >10.1016/j.jgar.2017.10.001</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    First description of the emergence of Enterobacter asburiae producing IMI-2 carbapenemase in the Czech Republic

  • Original language description

    The acquired class A carbapenemase IMI-1 was originally described in an Enterobacter cloacae isolated in a Californian hospital in 1984 [1]. Since their first description, IMI-type carbapenemases have occasionally been detected in Enterobacteriaceae from the USA, Europe, the Far East and South Africa. Here we report the case of an IMI-2-producing Enterobacter asburiae identified in the Czech Republic. In 2016, E. asburiae Easb-36567cz was recovered from a patient admitted to a Czech hospital. Easb-36567cz was isolated from a rectal swab during routine screening for carbapenemase-producing Enterobacteriaceae (CPE). Easb-36567cz was resistant to aminopenicillins, aminopenicillin/sulbactam combinations, second-generation cephalosporins, aztreonam, carbapenems and colistin but was susceptible to piperacillin/tazobactam, cefotaxime, ceftazidime and various non-beta-lactam antibiotics (Table 1). Carbapenemase production was hypothesised by a positive result in the matrix assisted laser desorption/ionization time of flight mass spectrometry (MALDI-TOF MS) imipenem hydrolysis assay [2]. Easb-36567cz tested negative by the ethylene diamine tetra-acetic acid (EDTA)–meropenem test, whilst the respective boronic acid–meropenem combined-disk test appeared positive indicating production of a class A carbapenemase. PCR and sequencing showed that Easb-36567cz carried blaIMI-2 [3].

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database

  • CEP classification

  • OECD FORD branch

    30100 - Basic medicine

Result continuities

  • Project

  • Continuities

    I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Others

  • Publication year

    2017

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Journal of Global Antimicrobial Resistance

  • ISSN

    2213-7165

  • e-ISSN

    2213-7173

  • Volume of the periodical

    11

  • Issue of the periodical within the volume

    DEC

  • Country of publishing house

    GB - UNITED KINGDOM

  • Number of pages

    2

  • Pages from-to

    98-99

  • UT code for WoS article

    000416992000020

  • EID of the result in the Scopus database

    2-s2.0-85032306295